Daniel P. van Plew, SVP & General Mgr IOPS at REGENERON PHARMACEUTICALS INC (REGN), sold 52,500 shares at $298.28 ($15.7M) on 2013-09-18, disclosed to the SEC on 2013-09-19.
Scheduled sale ($15.7M) by SVP & General Mgr IOPS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $294.75 | 2,992 | $882K | 5.6% |
| 2 | $294.75 | 25,531 | $7.5M | 48.0% |
| 3 | $298.28 | 3,777 | $1.1M | 7.2% |
| 4 | $299.34 | 2,800 | $838K | 5.3% |
| 5 | $300.62 | 2,600 | $782K | 5.0% |
| 6 | $301.42 | 1,400 |
| $422K |
| 2.7% |
| 7 | $303.01 | 600 | $182K | 1.2% |
| 8 | $304.16 | 1,444 | $439K | 2.8% |
| 9 | $305.14 | 3,556 | $1.1M | 6.9% |
| 10 | $306.40 | 3,600 | $1.1M | 7.0% |
| 11 | $307.28 | 3,200 | $983K | 6.3% |
| 12 | $308.26 | 1,000 | $308K | 2.0% |
| Total | $298.59 avg | 52,500 | $15.7M | 100% |
| Filing → |
| REGN | SELL | 2022-11-25 | $17.7M | — | Filing → |
| REGN | SELL | 2022-11-08 | $10.9M | — | Filing → |
| REGN | SELL | 2022-09-13 | $6.7M | — | Filing → |